Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 35,524 | reported | 14 May 2026 | tx 9+308,577−127,507 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 11,841 | — | 10b5-1 |
| 14 May 2026 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 5,746 | 35.58 USD | 10b5-1 |
| 14 May 2026 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 74,008 | — | 10b5-1 |
| 14 May 2026 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 35,912 | 35.58 USD | 10b5-1 |
| 14 May 2026 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 11,841 | 0.00 USD | 10b5-1deriv |
| 14 May 2026 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 74,008 | 0.00 USD | 10b5-1deriv |
| 04 Mar 2026 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 27,347 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 148,016 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 47,365 | 0.00 USD | deriv |